CVD Risk and Hormone Therapy
Learn the evidence and guidelines related to menopausal hormone therapy or selective estrogen receptor modulators in treating menopausal symptoms, including their role in CVD risk reduction.
Upon completion of this continuing education course, participants will be able to:
- Describe an evidence-based approach to shared decision making for the clinician and peri-menopausal patient considering menopausal hormone therapy or selective estrogen receptor modulators
- Cynthia Stuenkel, MD, NCMP